| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/30/2003 | US20030023066 For therapy and prophylaxis of Helicobacter infection |
| 01/30/2003 | US20030023061 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 01/30/2003 | US20030023057 Used in assaying for cancer, such as melanoma |
| 01/30/2003 | US20030023054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030023047 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer |
| 01/30/2003 | US20030023046 Vascular endothelial cell growth factor antagonists |
| 01/30/2003 | US20030023045 Reshaped human antibody to human medulloblastoma cells |
| 01/30/2003 | US20030023042 As pharmaceutical and diagnostic agents |
| 01/30/2003 | US20030023041 Method for designing specific ion channel blockers |
| 01/30/2003 | US20030023034 p27 (Kip1) -FKBP-12 protein complexes |
| 01/30/2003 | US20030022911 Detection of antibody mediated inflammatory auto-immune disorders |
| 01/30/2003 | US20030022860 CD40 binding molecules and CTL peptides for treating tumors |
| 01/30/2003 | US20030022858 Genes involved in the DNA regulation cascade (cell cycle disorders, DNA repair, tumorigenesis/tumor progression) which are associated with pathophysiology phenotype of Fanconi anaemia |
| 01/30/2003 | US20030022855 Melanoma differentiation associated gene-5 (mda-5) nucleic acids, proteins, and gene promoters for induction of apoptotic cell death |
| 01/30/2003 | US20030022849 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/30/2003 | US20030022822 Novel compounds |
| 01/30/2003 | US20030022819 Administering to an animal an angiogenic amount of a hedgehog polypeptide or agonist to promote angiogenesis |
| 01/30/2003 | US20030022813 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 01/30/2003 | US20030022812 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 01/30/2003 | US20030022339 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | US20030022338 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 01/30/2003 | US20030022331 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022328 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022325 Nucleotide sequences coding transport protein for use in diagnosis and treatment of cancers, kidney, bone and nervous sysem disorders |
| 01/30/2003 | US20030022308 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 01/30/2003 | US20030022291 Production of a multimeric protein by cell fusion method |
| 01/30/2003 | US20030022288 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 01/30/2003 | US20030022287 Non aggregating fluorescent proteins and methods for using the same |
| 01/30/2003 | US20030022284 Polypeptide for use in the diagnosis and treatment of kidney defects |
| 01/30/2003 | US20030022283 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 01/30/2003 | US20030022277 Nucleotide sequences coding polypeptide or use in the treatment of eating disorders |
| 01/30/2003 | US20030022275 Human nk-3 related prostate specific gene-1 |
| 01/30/2003 | US20030022272 Method of inducing an antigen-specific anticytotoxic cell |
| 01/30/2003 | US20030022262 Methods of detecting early renal disease in animals |
| 01/30/2003 | US20030022248 Accuracte detection and classification of preferential meat proteins; obtain meat sample with monoclonal antibody, monitor binding, evaluate bonding profile |
| 01/30/2003 | US20030022247 Inhibition of signal transduction for use as tool in treatment of cell proliferation disorders; obtain sample containing enzymatic polypeptide, incubate with modulator, monitor adjustment in phosphorylation activity |
| 01/30/2003 | US20030022244 Single chain antibody against mutant P53 |
| 01/30/2003 | US20030022240 Generation and affinity maturation of antibody library in silico |
| 01/30/2003 | US20030022238 Methods of identifying agents which inhibit GPR-9-6 |
| 01/30/2003 | US20030022232 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 01/30/2003 | US20030022226 Prophylactic and therapeutic monoclonal antibodies |
| 01/30/2003 | US20030022211 Nucleotide sequences coding polypeptide for use in diagnosis and prevention of psychological and nervous system disorders |
| 01/30/2003 | US20030022187 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022181 Streptococcus pneumoniae antigens |
| 01/30/2003 | US20030022178 Identification of sortase gene |
| 01/30/2003 | US20030022158 Peptide for use in the treatment of viral infection |
| 01/30/2003 | US20030022155 Nucleotide sequences for use in the detection of viral disease |
| 01/30/2003 | US20030021801 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia |
| 01/30/2003 | US20030021795 Administering antibody; determination binding to peptide |
| 01/30/2003 | US20030021794 Heat shock protein-based vaccines and immunotherapies |
| 01/30/2003 | US20030021790 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies |
| 01/30/2003 | US20030021789 Infection therapy |
| 01/30/2003 | US20030021788 Novel human STRA6-like protein and nucleic acids encoding the same |
| 01/30/2003 | US20030021785 Use of rank antagonists to treat cancer |
| 01/30/2003 | US20030021783 Interleukin antibody; antiinflammatory agents |
| 01/30/2003 | US20030021782 Antiporliferative agent |
| 01/30/2003 | US20030021781 Administering antibodies |
| 01/30/2003 | US20030021780 Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders |
| 01/30/2003 | US20030021779 Immunology response; monoclonal antibodies |
| 01/30/2003 | US20030021778 Ocular treatment by topical application of an immunoglobulin |
| 01/30/2003 | US20030021765 Polymer conjugates of interferon beta-1a and uses |
| 01/30/2003 | US20030021764 Methods of treatment of neurological diseases by interferon antagonists |
| 01/30/2003 | CA2493718A1 Methods for diagnosing and treating alzheimer's disease and parkinson's disease |
| 01/30/2003 | CA2454427A1 A novel g protein-coupled receptor, gave8 |
| 01/30/2003 | CA2454419A1 Invasion complex and methods of targeting |
| 01/30/2003 | CA2454345A1 Anti-tumor activity from reptile serum |
| 01/30/2003 | CA2454307A1 Human type antihuman ige receptor antibody and antibody fragment |
| 01/30/2003 | CA2454226A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | CA2454185A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | CA2453986A1 Glycoprotein vi fusion proteins |
| 01/30/2003 | CA2453967A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453965A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453662A1 Modification of human variable domains |
| 01/30/2003 | CA2453342A1 Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 01/30/2003 | CA2453249A1 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | CA2452421A1 Anti-microbial targeting chimeric pharmaceutical |
| 01/29/2003 | EP1279678A1 Gag antigen and other orf fragments of lav virus. Use for the detection of lav infection and in immunogenic compositions |
| 01/29/2003 | EP1279039A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 01/29/2003 | EP1278884A1 Immunoglobulin binding protein arrays in plant cells |
| 01/29/2003 | EP1278871A2 Human phospholipase c delta 5 |
| 01/29/2003 | EP1278870A1 Splice variant of camp phosphodiesterase type 7 (pde7a3) |
| 01/29/2003 | EP1278869A2 Proteases |
| 01/29/2003 | EP1278866A2 Serine-threonine kinase |
| 01/29/2003 | EP1278864A2 Serine-threonine kinase-3 |
| 01/29/2003 | EP1278863A2 Human serine-threonine kinase-4 |
| 01/29/2003 | EP1278859A2 Human protein kinases and protein kinase-like enzymes |
| 01/29/2003 | EP1278856A2 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 01/29/2003 | EP1278854A2 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/29/2003 | EP1278853A2 Listeria monocytogenes genome, polypeptides and uses |
| 01/29/2003 | EP1278851A1 Humanised antibodies to the epidermal growth factor receptor |
| 01/29/2003 | EP1278849A2 Thrombopoietin receptor modulating peptide |
| 01/29/2003 | EP1278848A1 New ras guanine-nucleotide-exchange factor 1 (nrg1) |
| 01/29/2003 | EP1278847A1 New gtpase-activating protein 1 |
| 01/29/2003 | EP1278846A2 Cytoskeleton-associated proteins |
| 01/29/2003 | EP1278843A2 Rna metabolism proteins |
| 01/29/2003 | EP1278842A2 Dna encoding the prost 03 polypeptide |
| 01/29/2003 | EP1278840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278839A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278830A2 Identification and uses of a hyaluronan receptor |